FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TAMRINTAMAB
异名/同义词IMMUNOGLOBULIN G1(226-SERINE), ANTI-(HUMAN DIPEPTIDASE 3) (HUMAN-MUS MUSCULUS MONOCLONAL SC34.28SS1 .GAMMA.1-CHAIN), COMPD. WITH HUMAN-MUS MUSCULUS MONOCLONAL SC34.28SS1 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS DPEP3 (DIPEPTIDASE 3)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-452) (VH (HOMO SAPIENS IGHV1-69*01 (85.7%)-(IGHD)-IGHJ6*01 (90.9%)) (8.8.16) (1-123)-HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (220) (124-221), HINGE C5>S (226) (222-236), CH2 (237-346), CH3 D12 (362), L14 (364) (347-451), CHS K>DEL (452)) (124-452)), NON-COVALENTLY ASSOCIATED WITH KAPPA LIGHT CHAIN HUMANIZED (1'-215') (VKAPPA (HOMO SAPIENS IGKV3D-20*01 (86.50%)-IGKJ2*01 (100.0%)) (7.3.9) (1'-108'),-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154), V101 (192) (109'-215'))DIMER (232-232'':235-235'')-BISDISULFIDE
TAMRINTAMAB
TAMRINTAMAB [INN]
CAS登记号2148325-59-9
物质唯一标识(Unique Ingredient Identifier)1QH1BNT9BK
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System